PEPTIDE
Tesamorelin
Growth Hormone Releasing Factor Analog
10mg $89Tesamorelin is a synthetic growth hormone releasing factor (GRF) analog consisting of the 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid modification at the N-terminus. This modification enhances metabolic stability while maintaining full GHRH receptor agonist activity in research applications.
Modified GHRH Analog
N-terminal trans-3-hexenoic acid modification provides enhanced resistance to enzymatic degradation compared to native GHRH.
GHRH Receptor Selectivity
Maintains selective agonist activity at the GHRH receptor, enabling targeted study of the GH-IGF-1 axis in research models.
Lipid Metabolism Research
Investigated in preclinical studies examining its effects on visceral adipose tissue and lipid metabolism pathways.
Tesamorelin: First approval for HIV-associated lipodystrophy research
Pharmacological profile and preclinical research data supporting tesamorelin's mechanism of action on the GH-IGF-1 axis.
| Product Name | Tesamorelin |
| CAS Number | 218949-48-5 |
| Molecular Formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
| Molecular Weight | 5135.87 Da |
| Purity | ≥99% (HPLC) |
| Physical Form | White Lyophilized Powder |
| Storage | -20°C, protected from light |
| Certification | Third-party HPLC & MS verified |
| Intended Use | Research and laboratory use only |
